Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Peritonsillar dexmedetomidine + ropivacaine versus tramadol + ropivacaine versus placebo + ropivacaine after tonsillectomy
IRCT20141209020258N163Phase 3Completed
- Sponsor
- Arak University of Medical Sciences
- Start
- Jul 2021
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in postoperative pain comparing Dexmedetomidine and ropivacaine group, Tramadol and ropivacaine group and Placebo and ropivacaine group (3 arms). Primary endpoints: Sedation, Pain and 1 more. Started Jul 2021; status: completed.
02
Drugs
dexmedetomidinetramadolropivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on IRCT20141209020258N163.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20141209020258N163.